BDSX: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	26M	22M	20M	18M	18M	18M
Research and development	3M	3M	3M	3M	3M	3M
Selling, general and administrative	24M	22M	22M	20M	20M	20M
Operating expenses	32M	29M	30M	27M	27M	26M
Operating income	−6M	−7M	−10M	−9M	−9M	−8M
Interest expense	—	—	—	—	—	2M
Net income	−8M	−9M	−11M	−11M	−10M	−11M
Earnings per share	−0.81	−1.16	−0.08	−0.08	−1.40	−0.08
Earnings per share, diluted	−0.81	−1.16	−0.08	−0.08	−1.40	−0.08
Weighted average shares	10M	8M	147M	147M	7M	127M
Weighted average shares, diluted	10M	8M	147M	147M	7M	127M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	26M	19M	17M	21M	18M	26M	31M	42M
Receivables	10M	9M	13M	7M	8M	9M	8M	10M
Current assets	41M	33M	33M	32M	30M	39M	44M	58M
Property, plant and equipment	24M	25M	25M	26M	27M	28M	29M	28M
Goodwill	15M	15M	15M	15M	15M	15M	15M	15M
Total assets	95M	87M	89M	88M	86M	97M	103M	116M
Current liabilities	14M	17M	18M	15M	13M	14M	13M	18M
Total liabilities	86M	90M	90M	87M	75M	76M	75M	80M
Equity	9M	−2M	−2M	1M	11M	21M	28M	36M
Shares outstanding	10M	8M	8M	147M	146M	7M	145M	145M
Shares issued	10M	8M	8M	147M	146M	7M	145M	145M

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	−10M	—	—	−9M	—	—
Depreciation and amortisation	1M	1M	1M	1M	1M	1M
Share-based compensation	1M	—	—	972,000	—	—
Capital expenditure	81,000	—	—	74,000	—	—
Investing cash flow	−144,000	—	—	−137,000	—	—
Financing cash flow	17M	—	—	97,000	—	—